Pharmabiz

Sekhmet Pharmaventures appoints Sumit Kumar as CCO and Jitendra Jalan as CHRO

Sekhmet Pharmaventures appoints Sumit Kumar as CCO and Jitendra Jalan as CHRO: Our Bureau, Mumbai Thursday, January 8, 2026, ...
Pharmabiz

Iksuda to present preliminary analysis of oesophageal cancer data from phase 1 study of IKS014 at ASCO Gastrointestinal Cancer Symposium

Iksuda to present preliminary analysis of oesophageal cancer data from phase 1 study of IKS014 at ASCO Gastrointestinal Cancer Symposium: Newcastle, UK Thursday, January 8, 2026, ...
Pharmabiz

Alkem launches Renocia cyclical therapy to support hair growth

Alkem launches Renocia cyclical therapy to support hair growth: Our Bureau, Mumbai Thursday, January 8, 2026, 17:30 Hrs [IST] Alkem Laboratories Ltd. has announced the launch of R ...
Pharmabiz

Granules gets US FDA tentative nod with 180-day exclusivity for generic amphetamine XR tablets

Granules gets US FDA tentative nod with 180-day exclusivity for generic amphetamine XR tablets: Our Bureau, Bengaluru Thursday, January 8, 2026, 16:15 Hrs [IST] Granules Pharmaceu ...
Pharmabiz

Immuneel with Impact Guru and CarePal Money to improve financial access to CAR T-cell therapy in India

Our Bureau, Bengaluru Thursday, January 8, 2026, 16:30 Hrs [IST] ...
Pharmabiz

Nimbus Therapeutics enters research collaboration with Lilly to develop novel oral treatment for obesity and other metabolic diseases

Nimbus Therapeutics enters research collaboration with Lilly to develop novel oral treatment for obesity and other metabolic diseases: Boston, Massachusetts Thursday, January 8, 2 ...
Pharmabiz

GSK reports positive results from B-Well 1 & B-Well 2 phase III trials for bepirovirsen, a potential first-in-class treatment for chronic hepatitis B

GSK reports positive results from B-Well 1 & B-Well 2 phase III trials for bepirovirsen, a potential first-in-class treatment for chronic hepatitis B: London, UK Thursday, January ...
Pharmabiz

PharmNXT expects integration of DTR to help both domestic and international markets

PharmNXT expects integration of DTR to help both domestic and international markets: Our Bureau, New Delhi Thursday, January 8, 2026, 17:15 Hrs [IST] Mumbai-based biotech start up ...
Pharmabiz

Oculis’ neuroprotective candidate privosegtor receives US FDA breakthrough therapy designation to treat optic neuritis

Oculis’ neuroprotective candidate privosegtor receives US FDA breakthrough therapy designation to treat optic neuritis: Zug, Switzerland Thursday, January 8, 2026, 17:00 Hrs [IS ...
Pharmabiz

BeOne Medicines’ Novel BCL2 inhibitor, sonrotoclax, achieves first-in-world approval in R/R MCL and R/R CLL/SLL

BeOne Medicines’ Novel BCL2 inhibitor, sonrotoclax, achieves first-in-world approval in R/R MCL and R/R CLL/SLL: San Carlos, California Thursday, January 8, 2026, 13:00 Hrs [IST ...
Pharmabiz

DCA Telangana raids illegal clinic in Hanumakonda, antibiotics and steroids seized

DCA Telangana raids illegal clinic in Hanumakonda, antibiotics and steroids seized: Our Bureau, Chennai Thursday, January 8, 2026, 13:30 Hrs [IST] The Drugs Control Administration ...
Pharmabiz

Sigachi Industries appoints Atul Dhavle as CPO

Sigachi Industries Ltd., a leading global manufacturer of pharmaceutical excipients and active pharmaceutical ingredients (APIs), has announced the appointment of Atul Dhavle as its chief people ...